(Total Views: 531)
Posted On: 04/12/2023 9:50:40 PM
Post# of 154436
Re: KenChowder #134077
Ken,
Sincere question. Who sponsored the study? Not Merck. I’m sure. I think MD Anderson in Houston. I thought it was a little more of a University setting instead of a BP setting.
Anyhoo. The combo data with a PD-1 inhibitor/blocker, such as Keytruda should yield positive results. Im just not convinced it means Merck has any interest in buying us for an amazing price. I hope I’m wrong.
One thing a set of solid data with LL being combined with a PD-1 Inhibitor/blocker should result in is simple. That the PD-1 blocked is no longer necessary.
GLTA
Sincere question. Who sponsored the study? Not Merck. I’m sure. I think MD Anderson in Houston. I thought it was a little more of a University setting instead of a BP setting.
Anyhoo. The combo data with a PD-1 inhibitor/blocker, such as Keytruda should yield positive results. Im just not convinced it means Merck has any interest in buying us for an amazing price. I hope I’m wrong.
One thing a set of solid data with LL being combined with a PD-1 Inhibitor/blocker should result in is simple. That the PD-1 blocked is no longer necessary.
GLTA
(2)
(0)
